This announcement is a separate document:
窪田製薬ホールディングス:研究開発及びその管理拠点を米国から日本に移管することによる経営合理化の決定
Kubota Pharmaceutical Holdings: Decision to rationalize management by transferring research, development, and management bases from USA to Japan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.